TRexBio (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- November 13, 2024
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $84,000,000
Company Info
- Founding Year
- 2018
- Organizations Involved
- Eli Lilly and Company, Johnson & Johnson Development Corporation (JJDC), Pfizer Venture Investments
- Founders
- SV Health Investors
- Company Description
- TRexBio is a biotechnology company developing purpose-built therapeutics by leveraging cutting edge computational biology tools, a focus on human tissue, and expertise in immunobiology. Our Deep Biology platform maps human tissue Treg behavior to disease processes to identify and characterize novel targets for therapeutic intervention.
- Market
- Therapeutics
- Location
- South San Francisco, California, USA
- Coinvestors
- Agent Capital, Alexandria Venture Investments, Avego Bioscience Capital, Delos Capital, Eli Lilly and Company, Johnson & Johnson Development Corporation (JJDC), Pfizer Venture Investments, Polaris Partners, SV Health Investors